Literature DB >> 12525592

Pathologic evaluation of a spherical polyvinyl alcohol embolic agent in a porcine renal model.

Gary P Siskin1, Kyran Dowling, Renu Virmani, Russell Jones, David Todd.   

Abstract

PURPOSE: To evaluate the effects of a spherical embolic agent consisting of polyvinyl alcohol (PVA) and to compare this agent with commercially available embolization agents.
MATERIALS AND METHODS: Eleven miniature pigs were included in the study population. The upper poles of both kidneys were selected as the target organs for embolization. PVA spheres (700-900 micro m) were used in nine kidneys, PVA particles (500-710 micro m) were used in six kidneys, gelatin spheres (700-900 micro m) were used in five kidneys, and gold-colored gelatin spheres (700-900 micro m) were used in three kidneys. Two animals were killed immediately after embolization. In the remaining animals, angiography was performed before sacrifice 7 days (in five pigs) or 28 days (in four pigs) after embolization. Pathologic and histologic evaluation of the kidneys was performed.
RESULTS: All agents resulted in target vessel occlusion and end-organ infarction. All arteries embolized with spherical agents were recanalized at follow-up angiography. In vessels embolized with PVA particles, the occluding plug consisted of thrombus and PVA. In vessels embolized with spherical agents, the occluding plug consisted mostly of the embolic agent. PVA spheres were associated with the mildest inflammatory responses at 7 and 28 days when compared with PVA particles and gelatin-based microspheres. Arterial wall destruction was seen to a greater extent in kidneys embolized with gelatin-based microspheres than in those embolized with PVA-based agents.
CONCLUSIONS: The spherical, PVA-based embolization agent resulted in target organ infarction and temporary arterial occlusion. The inflammatory response to PVA spheres was significantly less aggressive than the response to other agents tested. Further study with clinical and long-term pathologic follow-up is suggested to determine if these findings may have favorable clinical implications for patients undergoing embolization procedures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525592     DOI: 10.1097/01.rvi.0000052296.26939.4c

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  15 in total

Review 1.  Transcatheter embolization therapy in liver cancer: an update of clinical evidences.

Authors:  Yì-Xiáng J Wáng; Thierry De Baere; Jean-Marc Idée; Sébastien Ballet
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

Review 2.  Polymeric materials for embolic and chemoembolic applications.

Authors:  Azadeh Poursaid; Mark Martin Jensen; Eugene Huo; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2016-02-26       Impact factor: 9.776

3.  Calibrated Bioresorbable Microspheres as an Embolic Agent: An Experimental Study in a Rabbit Renal Model.

Authors:  Lihui Weng; Davis Seelig; Parinaz Rostamzadeh; Jafar Golzarian
Journal:  J Vasc Interv Radiol       Date:  2015-03-29       Impact factor: 3.464

Review 4.  Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?

Authors:  Eleni Liapi; Jean-Francois H Geschwind
Journal:  Cardiovasc Intervent Radiol       Date:  2010-11-12       Impact factor: 2.740

5.  Hepatic arterial embolization with doxorubicin-loaded superabsorbent polymer microspheres in a rabbit liver tumor model.

Authors:  Sanjay Gupta; Kenneth C Wright; Joe Ensor; Carolyn S Van Pelt; Katherine A Dixon; Vikas Kundra
Journal:  Cardiovasc Intervent Radiol       Date:  2011-04-09       Impact factor: 2.740

Review 6.  Particle Distribution in Embolotherapy, How Do They Get There? A Critical Review of the Factors Affecting Arterial Distribution of Embolic Particles.

Authors:  Reza Talaie; Pooya Torkian; Omid Amili; Yasmina Aboufirass; Nassir Rostambeigi; Hamed Jalaeian; Jafar Golzarian
Journal:  Ann Biomed Eng       Date:  2022-05-06       Impact factor: 3.934

7.  Tri-acryl gelatin microsphere is better than polyvinyl alcohol in the treatment of uterine myomas with uterine artery embolization.

Authors:  Yu Gao; Fang Jiang; Xinbo Wang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

8.  Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction.

Authors:  Angela C Rieger; Luiza L Bagno; Alessandro Salerno; Victoria Florea; Jose Rodriguez; Marcos Rosado; Darren Turner; Raul A Dulce; Lauro M Takeuchi; Rosemeire M Kanashiro-Takeuchi; Peter Buchwald; Amarylis C B A Wanschel; Wayne Balkan; Ivonne H Schulman; Andrew V Schally; Joshua M Hare
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

9.  Effect of renal embolization with trisacryl and PAVc.

Authors:  Leandro de Assis Barbosa; Jose Guilherme Mendes Pereira Caldas; Mario Luiz Conti; Denise Maria Avancini Costa Malheiros; Francisco Ferreira Ramos
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Drug eluting beads on cytology smears.

Authors:  Niti Manglik; Palam Annamalai; Ranjana S Nawgiri
Journal:  Cytojournal       Date:  2012-10-23       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.